Ticker: CRIS

Curis, Inc. (NASDAQ: CRIS) is a biotechnology company focused on developing emavusertib, an innovative small molecule inhibitor. The company reported its Q2 2025 financial results, providing insights into its performance and ongoing challenges. Key Financial Highlights for Q2 2025: Revenues: $2....